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Clusters of localized hypermutation in human breast cancer genomes, named “kataegis” (from the Greek for
thunderstorm), are hypothesized to result from multiple cytosine deaminations catalyzed by AID/APOBEC proteins.
However, a direct link between APOBECs and kataegis is still lacking. We have sequenced the genomes of yeast
mutants induced in diploids by expression of the gene for PmCDA1, a hypermutagenic deaminase from sea
lamprey. Analysis of the distribution of 5,138 induced mutations revealed localized clusters very similar to those
found in tumors. Our data provide evidence that unleashed cytosine deaminase activity is an evolutionary
conserved, prominent source of genome-wide kataegis events.
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Sequencing of cancer genomes has revealed that tumors
contain numerous mutations [1]. It is unclear how such
a large number of DNA sequence changes are induced
and what factors influence the distributions of the rates
of mutations among cells and within regions of the gen-
ome during tumor development. Recently, regions of
localized hypermutation, called kataegis, have been
detected in breast cancer genomes [2]. Based on the
prevalence of C:G->T:A transitions in these regions and
the sequence context of the mutations, it has been
hypothesized that mutation clusters in cancer are
induced by AID/APOBEC editing deaminases [2,3]. This
is consistent with the ability of deaminases to produce
multiple deaminations in ssDNA in vitro that can be
recovered as clustered mutations in bacteria [4,5]. Using
Sanger sequencing, Liu et al. discovered AID-induced
mutations in various loci in B-cells [6]. APOBEC3B can
introduce base substitutions (detected by 3D-PCR) in a
reporter gene integrated into the genome of a human* Correspondence: ypavlov@unmc.edu
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reproduction in any medium, provided the orcell line [7]. However, a direct link between APOBECs
and kataegistic clustered mutations has not been
reported. A yeast model is an efficient approach to study
this phenomenon. Regions of ssDNA are recognized as a
prerequisite for kataegis-like events induced by an alkyl-
ation agent in yeast, and by extrapolation, have been
proposed to be a prerequisite for the kataegistic action
of deaminases in humans [3]. Double-strand DNA
breaks in the vicinity of a reporter gene synergistically
stimulate mutagenesis by AID, and in yeast this behavior
might be related to the generation of ssDNA during
homologous recombination [8].
We examined kataegis induced in diploid yeast by the
most mutagenic AID/APOBEC protein, PmCDA1 from
sea lamprey [9]. AID/APOBECs belong to a superfamily
of proteins with diverse functions, from RNA editing to
humoral and innate immunity and DNA demethylation
[10]. Intriguingly, the basis of such a plethora of func-
tions is a relatively simple reaction: the deamination of
cytosine to uracil in ssDNA or RNA. During replication,
uracil pairs with adenine resulting in a C:G->T:A transi-
tions in the next round of replication. We expressed an
exogenous PmCDA1 gene in a diploid yeast strain
LAN210 defective for uracil-DNA-glycosylase (ung1).
The Ung1 protein excises uracil during base excisiond. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 (See legend on next page.)
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Figure 1 Improbable hotspots of mutagenesis induced by PmCDA1 in yeast genomes. A. Genome-wide distributions of mutation (also
called single nucleotide variants, SNVs) frequencies in PmCDA1 (red) and HAP (blue) induced mutants. SNV frequencies across the entire genome
are shown. Negative values (i.e., bars below the X axis) indicate regions of the genome excluded from analysis (mostly repetitive regions).
B. Distribution of 1 Kb windows with the indicated number of SNVs for PmCDA1 (red bars) and HAP (blue bars), log scale.
C. Same as B, but using a linear scale, and where values >5 are shown. D. Multiple alignment of the DNA sequences of the hypermutable
region on chromosome X from different mutant clones: LAN210-L1 – LAN210-L2 – clones used for genomic sequencing;
PmCDA1-cl1 – PmCDA1-cl4 – independent mutants with this region sequenced by the Sanger method; AID_cl2 and AID_cl8 – AID-induced
mutants that were found to contain mutations in this region. Homozygous G->A substitutions are red; heterozygous G->A substitutions
are blue Rs; heterozygous C->T substitutions are green Ys.
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yeast to APOBEC effects. At the same time, Ung1 defi-
ciency abrogates PmCDA1’s ability to induce mitotic re-
combination [9]. PmCDA1-induced canavanine-resistant
(Canr) mutants were selected and their genomes were
resequenced using the Illumina platform, which involved
the mapping of reads corresponding to the mutant
clones against a reference produced by DNA sequencing
and de novo assembly of the basic LAN210 genome. We
also sequenced the genomes of Canr mutants induced in
an isogenic diploid strain by the powerful base analog
mutagen 6-hydroxylaminopurine (HAP), one that also
(like PmCDA1 in the ung1 strains) is not excised by base
excision repair and does not induce recombination in
yeast ([11,12] and references therein). Therefore, the dis-
tributions of mutations obtained in our study represent
unbiased snapshots of genome-wide mutagen-induced
base substitutions.
To analyze the distribution of mutations in rese-
quenced genomes, we pooled the results from four gen-
omes of PmCDA1-induced mutants and eight genomes
of HAP-induced mutants. Each chromosome sequence
was divided into 1-Kbp intervals, and the number of
mutations per window was calculated. The mutation
densities were calculated across the entire genome and
plotted as a function of each interval’s chromosomal
coordinate for all 16 chromosomes (Figure 1A). The dis-
tributions of the intervals with a given number of muta-
tions are shown as insets in Figure 1B and C. Mutation
randomness analysis was done using C.A.MAN [13,14]
by calculating the threshold values of the mutation dens-
ities per window. The details of experimental procedures
are in Additional File 1 and in the article by AGL, Elena G.
Stepchenkova, Irina S.-R. Waisertreiger, Vladimir N. Nos-
kov, AD, James D. Eudy, RJB, MH, IBR and YIP, which is
currently under review. Analysis of the distribution of
HAP-induced mutations revealed three classes of windows.
The first class includes windows with 5 or less mutations,
the second class includes highly mutable regions (6 to 18
mutations). The threshold value of six mutations per win-
dow was chosen as for determining highly mutable win-
dows. Analysis of the PmCDA1-induced mutations also
revealed three classes of windows. The first class includes
windows with 4 or less mutations, the second class includeshighly mutable windows with 5 to 11 mutations per win-
dow, and the third class comprises obvious hypermutable
windows (number of mutations 14, 15, 17, and 22). The
threshold value of five mutations per window was chosen
for determining highly mutable windows. Thus, for the re-
spective classes of mutagenic agents, the thresholds for
highly mutable 1-Kb intervals were defined as those that
contained six or more HAP-induced mutations or five or
more PmCDA1-induced mutations.
Overall, we found that mutation densities ≥ 5 and ≥ 6
mutations per Kb (~0.078% for PmCDA1 and 0.046% for
HAP, respectively) indicate a non-random mutation in-
duction. We found 108 such regions for PmCDA1 and
24 for HAP (see Figure 1B, C and Table 1 for the distri-
butions of the actual counts of mutations per Kb).
These numbers underscore the striking differences
between the genome-wide distributions of PmCDA1-
and HAP-induced mutations in the sequenced clones
(Figure 1). Deaminase-induced mutation clusters are evi-
dent at various genomic loci (Figure 1A, red graphs),
whereas the density of HAP-induced mutations is much
more uniform (Figure 1A, blue graphs; see also
Figure 1B and C for mutation distributions). Very dense
clusters of deaminase-induced mutations were found on
chromosomes IV, V, VII, X, XII, XIV and XVI (Figure 1A).
The most striking example of a kataegistic deamination
cluster is on chromosome X (at chromosomal coordinate
~174000, between the URA2 and TRK1 genes, i.e., the
highest peak in chromosome X in Figure 1A). In this re-
gion, we observed 22 mutations in a 1,000 bp interval,
which corresponds to ~0.43% of the mutations found
in four genomes (yeast haploid genome size is ~12 Mb).
All four sequenced clones possess mutations in this
region (Figure 1D). These results were confirmed by
Sanger sequencing. We PCR-amplified ~2,100 bp be-
tween the URA2 and TRK1 genes and sequenced the
resulting product using three primers (primer sequences
are available upon request). In contrast, mutation clusters
were practically not found in the genomes of HAP-
induced mutants. Sequencing of the region between
URA2 and TRK1 in four independent PmCDA1-induced
mutants confirmed that this genomic region is highly
prone to dense mutation clusters caused by localized
“thunderstorms” of enzymatic deamination. At position




























Highly mutable regions are shown in bold and underlined.
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in 6 out of 8 clones, and this mutation was homozygous
in 5 clones (Figure 1D). Given the average mutation load
in mutant clones and the GC content of the yeast genome,
the probability of observing this by chance is ~9x10-43,
assuming independent mutations on homologous chro-
mosomes. We also sequenced this hypermutable region in
Canr mutants induced by a different deaminase, human
AID, and found mutations in 2 out of 12 clones
(Figure 1D). Since this AID is less active than PmCDA1 in
yeast, we concluded that hypermutability of this region is
independent of the deaminase studied, i.e., it has certain
fundamental properties making it prone to mutation in-
duction by these enzymes. In addition, a strong strand bias
was found in this region (predominantly G->A mutations),
which may be a result of preferential deamination on the
non-transcribed strand of nearby genes.
The clusters of cytosine deaminase-induced mutations
described here are very similar to those found in cancer
cells [2,3]. They can be explained by the processive activ-
ity of AID/APOBEC enzymes [4] in genomic regions
where ssDNA is exposed and is highly accessible to the
deaminase. The level of adjacent transcription is one ofthe factors that can influence the accessibility of gen-
omic DNA to deaminases. Our results establish, for the
first time, a direct link between cytosine deaminases and
kataegis. It should be noted that in our system the in-
duction of homologous recombination was suppressed,
either by the nature of the mutagen (HAP) or the use of
ung1 strains for PmCDA1. This makes our model more
similar to human cells where this type of recombination
is relatively rare. The use of diploid strains was also crit-
ical for uncovering the full mutagenic potential of the
deaminase. In terms of inter-mutation distances, the
strongest mutation clusters observed in our study (such
as the one shown on Figure 1D) resemble the micro-
clusters found in the macro-clusters in the kataegistic
regions of breast cancer genomes (See Figure 4A in [2]).
We found that PmCDA1 predominantly introduces
mutations in ATC motifs (more details in the manu-
script under review, see above). Similarly, a group of
mutations in breast cancer kataegis is characterized by a
TCX motif signature. Further studies will reveal if
PmCDA1, a lamprey enzyme, possesses a conserved spe-
cificity. Importantly, our study reveals that the AID/
APOBEC proteins can induce kataegis in the genome.
The nature of the deaminase participating in this process
will dictate the sequence motifs where mutations occur.
These findings have broad implications for cancer biology
and evolution, especially in the context of the recent discov-
ery of AID/APOBEC-like proteins in various prokaryotes
and eukaryotes [15]. Thus, kataegis might be a widespread
phenomenon in the evolution of different forms of life. Re-
cently, localized mutation clusters were discovered in yeast
mutants obtained by a different mutagen, methyl metane-
sulfonate (MMS) [3]. At present it is not possible to predict
the impact of kataegis on the existing evolutionary models
of mutation frequencies, which assume the independence
of mutation events. Kataegis may also significantly influence
the outcome of other studies of discrete evolutionary
events, e.g. the detection of recombination patches.
Additional file
Additional file 1: Supplementary Experimental Procedures.
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Reviewers’ comments
Reviewer's report
Title: AID/APOBEC cytosine deaminase induces genome-wide mutation
clusters
Version: 1




Regions of localized hypermutations – so-called kataegis regions – were
recently found to be colocalised with regions of somatic genome
rearrangements in cancer genomes. As C:G->T:A transitions were
overabundant in these regions, it was hypothesized that AID/APOBEC
editing deaminases that are responsible for cytosine to uracil deamination in
single-stranded DNA or RNA, may be one of the causative agents generating
localized hypermutations. However plausible in the chemical sense, this
hypothesis is difficult to prove by experiment. In this Discovery Note, Lada
et al. describe an experiment designed to provide a very interesting piece of
supporting evidence to this hypothesis. The authors used a diploid yeast
sensitized to deamination effects by the removal of the uracil DNA
glycosylase gene (ung1) as the model organism. Then they expressed a
hyperactive AID/APOBEC protein from sea lamprey in this organism and
explored the distribution of mutations along the chromosomes. It was found
that distribution of these mutations is highly uneven, and the differeces are
especially striking in comparison with those induced by the base analog
mutagen 6-hydroxlaminopurine (HAP) which was used as a control. The
findings are straightforward and provide strong support to the hypothesis
that unleashed AID/APOBEC may be the causative agents of hypermutations
found in cancer genomes. The link between the two phenomena is that
clusters of deaminase-induced mutations in yeast are very similar to those
found in cancer cells. It would be very interesting to see a more detailed
description of this similarity. Are there similarities in the sequence contexts?
It is a convincing argument that HAP-induced mutations in ung1- mutants
are entirely random, but perhaps there are other examples of or analogies
with more uneven mutations in the literature where, for instance, the
context of the mutations are different.
Author’s response: We are glad that Dr. Pongor considered our study
interesting and convincing. We would like to thank Dr. Pongor for the
constructive suggestions on manuscript improvements. We have discussed the
sequence context of the mutations found in our study and in breast cancer
samples, as well as the recent paper (Roberts et al.) where clustered mutations
were induced in yeast by a different mutagen-MMS.
The experiments are complex, and the details are described in an
experiment under review. I would suggest the authors add a brief
description of the experiment as an appendix to this note.
Author’s response: As suggested, we have added a short overview of
experiments undertaken. We also provide more details in the responses to
Reviewer #3. In addition, since the format of the Discovery Notes is adapted to
the short communications, we refer the interested readers to the paper (Lada
et al.) that is currently under review. This paper contains the details of
experiments undertaken.
In summary, I find the experiment well-designed and the conclusions
convincing.
Reviewer’s response: I accept the revisions.
Quality of written English: Acceptable
Reviewer's report
Title: AID/APOBEC cytosine deaminase induces genome-wide mutation
clusters
Version: 1Date: 15 November 2012
Reviewer number: 2
Professor Shamil R. Sunyaev
Report form:
I find this manuscript to be of great interest. Two recent publications
reported presence of mutation clusters induced by APOBEC proteins in
cancer genomes, shedding new light on the nature of spontaneous somatic
mutagenesis. This manuscript provides experimental evidence supporting
the hypothesis of recent observational studies. The authors report that
genomes of yeast mutants carrying the hypermutagenic deaminase
contained mutation clusters highly similar to clusters (putatively caused by
APOBECs) observed in tumor genomes. This is an important result and I
have no suggestions for improvements.
Author’s response: We are excited that Professor Sunyaev found our work to be
of great interest and that it provides new information on spontaneous
mutagenesis.
Reviewer’s response: I did not have any concerns with the manuscript.
Quality of written English: Acceptable
Reviewer's report
Title: AID/APOBEC cytosine deaminase induces genome-wide mutation
clusters
Version: 1




Recent papers (2,3) have provided detail descriptions of clustered mutation
sites in the genomes of four human cancers and in yeast cells. In (3)
functional and structural association of APOBEC proteins with clustered
mutation have been suggested. However, more direct functional associations
of APOBEC family member(s) proteins with clustered mutations have to be
carrying out. In this study, the authors used sequencing technique and their
yeast model to study genome clusters of hypermutation activity of
deaminases PmCDA1 and AID.
Major concerns and my recommendations:
1. Analysis of the literature is essentially incomplete
The authors claimed: “. . . a direct link between APOBEC deaminase
activity and genome-wide hypermutagenesis is still lacking.” However,
this claim has to be debated. Atomic force microscopy studies
provided direct evidence of the structural details of direct interaction
of APOBEC3G with ssDNA on a specific site at a sing molecular level
and at nanometer resolution (Shlyakhtenko et al., 2011). Yamane et al.
(2011) reported about deep sequencing analysis of mutations and
identification of the genomic targets of AID in mouse B-cells and
provided the evidences of association of ssDNA hypermutation sites
with APOBEC binding motif. At least two papers reported functional
and structural connection between AID/APOBECs and genome-wide
hypermutation (Klein et al. 2011; Yamane et al. 2011). Both papers
studied the impact of AID in mouse B-cells at the genome scale.
Author’s response to 1: We thank Dr. Kuznetsov for extensive review of our
paper that took significant effort and almost two months. In response to the
critique we added a more balanced discussion of the papers that we deemed
ultimately related to our study (references 2–8). As to papers mentioned by the
reviewer, a very interesting article by Yamane et al. (2011) is devoted to the
construction of ChIP-based whole-genome maps of AID and RPA occupancies
and is neither analyzing genome-wide mutation distributions nor report the
discovery of clustered mutations. Moreover, in our opinion, interpretation of the
very solid experimental results of this study should be re-considered, because
they are in direct disagreement to data obtained in our lab (Lada et al., 2011)
and by Dr. Myron Goodman’s group (Pham et al., 2008; Chelico et al., 2009).
The paper by Klein et al. (2011) presents a very thorough genome-wide study
where the authors used a powerful translocation-capture sequencing method to
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report that translocation hotspots were accompanied by the base substitutions,
we would like to point out that, similar to the paper by Yamane et al. (2011),
the genome-wide mutagenesis study is not performed in this study and
mutational clusters are not detected. Moreover, the paper by Nik-Zainal (2012)
reporting the discovery of kataegis and discussing the potential involvement
of the APOBEC protein in the formation of clusters of mutations was
published later than all of the mentioned papers. In addition, studies of
activated B-cells, which provide the natural environment for the AID
activity, do not explain how the genomes of breast cells become edited by
the APOBEC proteins.
2. There is no description of the sequencing methods. Even the number of
reads was not reported.
3. Raw and processed data are not available.
4. Sequencing generation, sequence data analysis, genome assembly and
mapping procedures and results of these steps omitted.
Author’s response to 2–4: The format of the Discovery Notes does not allow us
to include all the Materials and Methods related to our data. We refer to our
parallel paper (Lada et al., currently under review) where all the details of
experimental procedures and data analysis are described in detail. However, we
have added a short description of materials and methods used in this
manuscript, including the numbers of reads, coverage and the NCBI accession
number for the raw data. This text is available as an Additional File 1.
5. Authors did not provide systematic evidences of accuracy of their finding.
Statistical model(s) of background noise, testing methods, and analysis of
experimental results are not reported. There are no any estimates of
specificity and sensitivity of the proposed experimentally detected mutation
sites and clustered mutations associated with PmCDA1 and AID activity.
Author’s response to 5: All draft reference genome assemblies performed in this
study were manually edited and assembly errors were excluded from analysis. The
remaining questionable few regions were sequenced using the Sanger method to
confirm or reject the SNVs detected. The detailed description of these procedures is
beyond the scope of the Discovery Notes, see response to comments 2–4.
6. A work needs to develop an analysis of the boundaries of clustered
mutations; result should include the frequency tables of all observed
mutation transitions occurred in clustered mutation as well as in the regions
out of the clusters.
Author’s response to 6: There are methods to analyze the clustering of
mutations that attempt to locate the boundaries of the regions with an
elevated frequency of mutations (P.J. Gearhart, D.F. Bogenhagen, 1983. Clusters
of point mutations are found exclusively around rearranged antibody variable
genes. Proc. Natl. Acad. Sci. U.S.A. 80, 3439–3443; H. Tang, R.C. Lewontin 1999.
Locating regions of differential variability in DNA and protein sequences.
Genetics 153, 485–495). These methods, however, require a much higher
frequency of mutations per nucleotide and were tested for relatively short
sequences.
We have used a classification approach to analyze the distribution of mutations
across yeast chromosomes using non-overlapping windows. This method is not
capable of finding the exact boundaries of hypermutable regions, however it
allows for the detection of the general trends in a robust way. It is described in
more details in the revised draft and in new Additional File 1.
7. There are no final lists of clustered mutations and their genome
coordinates and biological interpretation.
Author’s response to 7: We have added Table 1, which contains distribution of
mutations in 1 Kb windows.
8–9. The number of C to T substitution mutation is reported only for two
genes on chrX; There are no quantitative data and numerical/statistical
characteristics for clustered mutation sites, any other genes, regions and
chromosomes.9. Statistical distributions of all base transitions (e.g. % of C to
T, G to A etc.) should be presented and discussed. The work should providemutation’ classification and include description of the substitution mutation
in the clusters on positive and negative strands and supporting by APOBEX/
AID motif(s) co-localization.
Author’s response to 8–9: See response to comments 2–4.
10. There is no comparison of the results of this genome-wide finding with
alternative studies.
Author’s response to 10: We have included a more extensive discussion of the
results by Roberts et al. (2012).
11. A reason of using 6-hydroxlaminopurine (HAP) treated cells as a negative
control should be explained.
Author’s response to 11: We are especially grateful for this comment. One
of the major emphases of the paper is to study mutagenesis in diploid
yeast independent of recombination, which is uniquely frequent in this
organism. We have chosen conditions and mutagens when induced
recombination is suppressed and the situation is closer to processes in
human cells (both HAP and PmCDA1 in ung1- strains does not induce
recombination in yeast). We have updated the text accordingly to make
this more transparent.
Summary:
This work is essentially incomplete and poorly performed; there is no way to
reproduce its methods, results and evaluate their actual value.
Author’s response: See answers to comments 2–4 and 8–9. We also think that
even without the knowledge of fine experimental details there is a
straightforward way to reproduce the results of this work by expression of
PmCDA1 gene in diploid ung1- yeast strain or treatment by HAP, selection of
mutants and genome sequencing.
Quality of written English: Not suitable for publication unless extensively
edited
Author’s response: Please see evaluation by reviewers 1 and 2. Nevertheless, we
have put forth additional effort and we have carefully edited the manuscript.
Reviewer’s response:
1. “. . ..clusters very similar to those found in tumors”.
What kind of parameter(s) is similar? What kind of similarity/dissimilarity
measure(s) between mutation clusters in yeast and human cancer genomes
was used? Is there some statistical estimation? If it is statistical-based analysis,
the test and confidence values should be reported.
2. “We also think that even without the knowledge of fine experimental details
there is a straightforward way to reproduce the results of this work by
expression of PmCDA1 gene in diploid ung1- yeast strain or treatment by HAP,
selection of mutants and genome sequencing.”
Unfortunately, NGS is not well matured and standardized technic, specifically,
in context of ‘The details’ of experimental procedures, data analysis and
interpretation. Perhaps many readers of BD whose have an experience to
use NGS technics and corresponding analytical method, should disagree
with the authors point. Specifically -processing, alignment, mapping results
and analysis of data are not trivial steps and are usually reported in
publications as regular (not referred to unpublished data). As usual
publication practices, it should be presented in suppl. file.
3. “primer sequences are available upon request”.
Why? This information should be present in the work, if no commercial interest.
4. “Importantly, our study reveals that the AID/APOBEC proteins can induce
kataegis in the genome”
This conclusion should be too strong. The inducer(s) of “kataegis” were not
defined; it might be identified in future works.
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evolutionary conserved, prominent source of genome-wide kataegis events.”
It might be too strong conclusion. The evidences of the evolution
conservation of cytosine deaminase activity in “genome-wide kataegis” loci
across species were not reported and they should be done for specific
kataegis loci if any.
6. Minor: NGS Instrument model should be indicated in the manuscripts.
Quality of written English: Acceptable.
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